Scientific Publications Database
Article Title: EarLEE-2: A phase 3 study of ribociclib plus endocrine therapy (ET) for adjuvant treatment of patients with hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-), intermediate-risk, early breast cancer (EBC)Authors: O'Shaughnessy, Joyce; Alba, Emilio; Bardia, Aditya; Dent, Susan; Dieras, Veronique; Hortobagyi, Gabriel; Im, Seock-Ah; Montemurro, Filippo; Untch, Michael; Yardley, Denise A.; Chakravartty, Arunava; Germa, Caroline; Miller, Michelle; Slamon, Dennis
Journal: CANCER RESEARCH Volume 78 Issue 4
Date of Publication:2018
Abstract:
.